Low-dose zolpidem-induced visual hallucinations in prodromal dementia with Lewy bodies.

[1]  Y. Hara,et al.  Psychotic Features Among Patients in the Prodromal Stage of Dementia with Lewy Bodies During Longitudinal Observation. , 2021, Journal of Alzheimer's disease : JAD.

[2]  Alan J. Thomas,et al.  Research criteria for the diagnosis of prodromal dementia with Lewy bodies , 2020, Neurology.

[3]  M. Onofrj,et al.  The Pharmacology of Visual Hallucinations in Synucleinopathies , 2019, Front. Pharmacol..

[4]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[5]  D. Hibbs,et al.  Spontaneous Adverse Event Reports Associated with Zolpidem in the United States 2003-2012. , 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[6]  C. Tsai,et al.  Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study. , 2015, The Journal of clinical psychiatry.

[7]  A. Cagnin,et al.  Combined duloxetine and benzodiazepine-induced visual hallucinations in prodromal dementia with Lewy bodies. , 2013, General hospital psychiatry.

[8]  T. Miyaoka,et al.  Adverse reactions to zolpidem: case reports and a review of the literature. , 2010, Primary care companion to the Journal of clinical psychiatry.

[9]  T. Asada,et al.  Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder. , 2016, Journal of Alzheimer's disease : JAD.

[10]  D. V. van Kammen,et al.  The interaction between GABA and dopamine: implications for schizophrenia. , 1983, Schizophrenia bulletin.